NCT07226999 2026-01-12A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Extensive-Stage Small Cell Lung CancerPfizerPhase 2/3 Recruiting550 enrolled